Rallybio Corp

RLYB chart

Rallybio Corp news

• Rallybio Announces Reverse Stock Split Ahead of Merger

  TipRanks · Nov 10, 6:17 PM EST

• Rallybio to become oncology player Avenzo, backed by $215M placement

  Dealroom · Nov 10, 5:58 PM EST

• Rallybio announces 1-for-2 reverse stock split effective Nov. 20

  Investing.com · Nov 10, 5:56 PM EST

• Rallybio sets one-for-two reverse split ahead of planned merger with Avenzo

  TradingView · Nov 10, 5:52 PM EST

• A November 20 reverse split is expected for Rallybio (RLYB) ahead of its anticipated merger.

  Stock Titan · Nov 10, 5:50 PM EST

• A November 20, 2026 reverse split is expected at Rallybio (RLYB) ahead of its anticipated Avenzo merger.

  Stock Titan · Nov 10, 5:50 PM EST

• RLYB: Rallybio to reverse split 1-for-2 ahead of Avenzo merger

  Quantisnow · Nov 10, 5:26 PM EST

• Rallybio Sets 1-for-2 Reverse Stock Split Ahead of Proposed Avenzo Merger

  TradingView · Nov 10, 5:23 PM EST

• Rallybio Announces Reverse Stock Split of Common Stock in Connection with the Proposed Merger with Avenzo

  Yahoo Finance · Nov 10, 5:15 PM EST

• Rallybio postpones merger closing with Avenzo Therapeutics, delays cash distribution

  Investing.com · Nov 6, 6:20 PM EST

• RLYB: Rallybio postpones Avenzo merger closing, delays cash distribution

  Quantisnow · Nov 6, 5:35 PM EST

• Rallybio Postpones Merger Closing Pending Listing Approvals

  TradingView · Nov 6, 5:33 PM EST

Rallybio Corp key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 8-K8-K2026-11-10
• 8-K8-K2026-11-06
• 8-K8-K2026-11-04
• 10-Q10-Q2026-10-27
• 8-K8-K2026-10-26
• 8-K8-K2026-09-09
• 10-Q10-Q2026-08-06
• 8-K8-K2026-06-01
• 10-Q10-Q2026-05-13
• 8-K8-K2026-05-04
• 8-K8-K2026-03-31
• 10-K10-K2026-03-16

About Rallybio Corp

Ticker

RLYB (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

New Haven, CT

Incorporated in

DE

Fiscal year end

December 31

SEC CIK

1739410

Former names

Rallybio Holdings, LLC

Frequently asked questions